tykhr
sign in
free sign up
Comera Life Sciences Holdings Inc
Biotechnology
Healthcare
CMRA
19.09 M shares
NASDAQ US
traded
15 Feb 2023
listed
no
open
1.36
52 week high
11.23
high
1.37
52 week low
1.17
low
1.30
growth
-84.97 %
previous Close
1.34
P/E ratio
-1
market cap
53.44 M
div yield
0
usd
Jun 2022
qoq
revenue
147 K
-100.00 %
net incoming
-9.09 M
0.00 %
eps
-1.14 %
-924.06 %
eps surprise
0.00 %
net profit margin
-6192.00 %
-61.92 %
operating incoming
-3.97 M
100.00 %
net change in cash
0.00 %
cash on hand
4.94 M
-100.00 %
cost of revenue
54.54 K
-100.00 %
top